Sad???? Are you kidding me? The fact is this tax credit are finds that go straight to NRTI's bottom line. It's not a matter if we get tax credits this, but rather how much. Mr. James filed for the remaining balance of around $3 million and said they should have a very good chance of getting approved for the remaining balance. Our CEO has went to these extraordinary lengths to get these funds to support the company's operational and promotional cost, without turning to dilution.
When one does their true DD they understand what is going on with company and where they are headed. Knowledge is power and it is through my knowledge about this company that I remain very optimistic about their future. The new CEO and his new management team have already accomplished so much in their 1st year to turn this company around.
What the company needs is exposure and that is the reason Mr. James is in the midst of hiring a reputable IR firm to bring the much needed attention to investors. The news about the big tax credits is something that needs to be brought to the attention of investors and exactly what it means for the company. Last year BiomedReports did an article on the $2.2 million they received and what it meant for the company. I expect them to do the same this year. That combined with a new IR firm would be a great way to kick start the stock for the new year. I am hoping he makes an announcement soon, but I understand that he wants to take the time to find the right firm.
Cheers!
News 
Market Data 
Discover 
